NCT00144547View on ClinicalTrials.gov

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JP

PHASE3CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

August 31, 2008

Study Completion Date

June 30, 2009

Conditions
Rheumatoid Arthritis
Interventions
DRUG

MRA(Tocilizumab)

8mg/kg(i.v.)/4weeks

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY